<DOC>
	<DOC>NCT02633644</DOC>
	<brief_summary>The purpose of the ENDO-HF study is to determine the safety &amp; performance of the Harmony System for the treatment of heart failure</brief_summary>
	<brief_title>Endovascular NeuromoDulation Treatment fOr Heart Failure Patients (ENDO-HF)</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Subject is diagnosed as chronic heart failure NYHA class IIIII Subject should be receiving optimal medical treatment Subject signed and dated informed consent Subject has severe aortic sclerosis or calcification Subject diagnosed with severe aortic valve disease Subject has severe mitral stenosis Subject involved in any concurrent clinical investigation Subject with cerebral vascular accident or transient ischemic attack prior to enrollment Subject diagnosed with Marfan Syndrome Subject with moderate or severe chronic obstructive lung disease Subject is allergic to iodine or contrast media Subject with prior cardiac transplant or heart transplant candidate Subject with a life expectancy of less than 12 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Heart Diseases</keyword>
</DOC>